for windows version 4.2 (MedCalc Software Ltd)
90
Structured Review
MedCalc Software Ltd
for windows version 4.2
For Windows Version 4.2, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/windows+version+4%2E2/windows+version+4+2/pm32698637-48-22-25
Average 90 stars, based on 1 article reviews
For Windows Version 4.2, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/windows+version+4%2E2/windows+version+4+2/pm32698637-48-22-25
Average 90 stars, based on 1 article reviews
for windows version 4.2 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Comparison of the model for end-stage liver disease (MELD), MELD-Na and MELDNa for outcome prediction in patients with acute decompensated hepatitis. Article Snippet: Background and aim: The model for end-stage liver disease (MELD) is used to predict the outcome of patients with cirrhosis.. Incorporation of serum sodium (Na) into MELD may further increase its prognostic ability.. Two Na-containing MELD models, MELD-Na and MELDNa, were proposed to enhance the prognostic ability. Article Title: The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance. Article Snippet: TEH-IA HUO, MD,* CHENG-YUAN HSIA, MD, CHI-JEN CHU, MD, YI-HSIANG HUANG, MD, PhD, WING-YIU LUI, MD, PhD, JAW-CHING WU, MD, PhD, PUI-CHING LEE, MPH, CHIN-WEN CHI, PhD, AND SHOU-DONG LEE, MD Institute of Pharmacology, National Yang-Ming University School of Medicine, Taipei, Taiwan Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei, Taiwan Article Title: The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey. Article Snippet: The MELD-Na is an independent shortand long-term prognostic predictor for hepatocellular carcinoma: A prospective survey T.-I.. Huo a,e,∗, H.-C. Lin a,f, C.-Y.. Hsia b,f, Y.-H. Huang a,g, J.-C. Wu c,g, J.-H. Chiang d,f, Y.-Y. Article Title: Prognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapy Article Snippet: All statistical analyses were conducted using SPSS for Windows version 14 (SPSS Inc., Chicago, IL, USA) and MedCalc for Article Title: Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis. Article Snippet: The comparison of the AUCs and the examination of the statistical significance were done with the method of Hanley and McNeil.23 All statistical analyses were conducted with the SPSS for Windows version 14 release (SPSS, Inc., Chicago, IL), SAS version 9.1 (SAS, Cary, NJ), and MedCalc for Article Title: Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score. Article Snippet: 0168-8278/$30.00 q 2005 European Association for the doi:10.1016/j.jhep.2005.01.019 Received 20 July 2004; received in revised form 24 accepted 15 January 2005; available online 31 March 2 * Corresponding author.. Address: Department of M Veterans General Hospital, Taipei, Taiwan, ROC.. Tel 2121x3352; fax: C886 2 2873 9318/C886 2 2876 1641 E-mail address: tihuo@vghtpe.gov.tw (T.-I. Article Title: A novel prognostic model based on serum levels of total bilirubin and creatinine early after liver transplantation. Article Snippet: DOI:10.1111/j.1478-3231.2007.01494.x Abstract Background/aim: We aim to evaluate the impact of early renal dysfunction (ERD), early allograft dysfunction (EAD) on post-transplant mortality, and further explore a simple and accurate model to predict prognosis.. Patients: A total of 161 adult patients who underwent liver transplantation for benign end-stage liver diseases were enrolled in the retrospective study.. Another 38 patients were used for model validation. |